BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15096563)

  • 1. Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data.
    Koga T; Horio Y; Mitsudomi T; Takahashi T; Yatabe Y
    J Mol Diagn; 2004 May; 6(2):90-5. PubMed ID: 15096563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers.
    Sasaki E; Tsunoda N; Hatanaka Y; Mori N; Iwata H; Yatabe Y
    Mod Pathol; 2007 Feb; 20(2):208-14. PubMed ID: 17192791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy.
    Okasaka T; Usami N; Mitsudomi T; Yatabe Y; Matsuo K; Yokoi K
    J Surg Oncol; 2008 Dec; 98(7):510-4. PubMed ID: 18802955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
    Ghadersohi A; Sood AK
    Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category.
    Gimbergues P; Dauplat MM; Cayre A; Durando X; Le Bouedec G; Finat-Duclos F; Portefaix G; Kwiatkowski F; Dauplat J; Penault-Llorca F; Tchirkov A
    Eur J Surg Oncol; 2007 Feb; 33(1):16-22. PubMed ID: 17071045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of expression based markers for the detection of breast cancer cells.
    Brown NM; Stenzel TT; Friedman PN; Henslee J; Huper G; Marks JR
    Breast Cancer Res Treat; 2006 May; 97(1):41-7. PubMed ID: 16319979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.
    Yan Z; Gidley J; Horton D; Roberson J; Eltoum IE; Chhieng DC
    Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique expression patterns and alterations in the intestinal protein villin in primary and metastatic pulmonary adenocarcinomas.
    Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Dec; 23(4):234-42. PubMed ID: 9869452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium.
    Miksicek RJ; Myal Y; Watson PH; Walker C; Murphy LC; Leygue E
    Cancer Res; 2002 May; 62(10):2736-40. PubMed ID: 12019145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer.
    Ignatiadis M; Kallergi G; Ntoulia M; Perraki M; Apostolaki S; Kafousi M; Chlouverakis G; Stathopoulos E; Lianidou E; Georgoulias V; Mavroudis D
    Clin Cancer Res; 2008 May; 14(9):2593-600. PubMed ID: 18451221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
    Ouellette RJ; Richard D; Maïcas E
    Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
    Chia SY; Thike AA; Cheok PY; Tan PH
    Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
    Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
    Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
    Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
    Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous detection of multiple mRNA markers CK19, CEA, c-Met, Her2/neu and hMAM with membrane array, an innovative technique with a great potential for breast cancer diagnosis.
    Chen CC; Hou MF; Wang JY; Chang TW; Lai DY; Chen YF; Hung SY; Lin SR
    Cancer Lett; 2006 Aug; 240(2):279-88. PubMed ID: 16289546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time.
    Span PN; Waanders E; Manders P; Heuvel JJ; Foekens JA; Watson MA; Beex LV; Sweep FC
    J Clin Oncol; 2004 Feb; 22(4):691-8. PubMed ID: 14966093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammaglobin, a potential marker of breast cancer nodal metastasis.
    Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH
    J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-Specific Ets (PSE) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodes.
    Mitas M; Mikhitarian K; Hoover L; Lockett MA; Kelley L; Hill A; Gillanders WE; Cole DJ
    Br J Cancer; 2002 Mar; 86(6):899-904. PubMed ID: 11953821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.